Form D · Manufacturing
Curax Scientific, LLC
St. Louis, MO · CIK 0001560451
Offering snapshot reported Oct 17, 2012 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-185672
Private Placement Memorandum printed October 10, 2012, which initiated capital raise process.
Source: Form D, filed Oct 17, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Douglas Lindblad | Director, Executive |
| Amod Prabhakar Paranjpe | Director, Executive |
| Anthony Jamie Riley | Director, Executive, Promoter |
| Gary James Schmidt | Director, Executive |
| Daniel Alan Shipley | Executive |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
9967 Lin Ferry Rd
St. Louis, MO, 63123
St. Louis, MO, 63123